A Systematic Review of the Benefits and Risks of Anticoagulation Following Traumatic Brain Injury

Journal of Head Trauma Rehabilitation

Volumn 30, Issue 4, 2015, Pages E29-E37

  Shen, Xian ^a   Dutcher, Sarah K ^a   Palmer, Jacqueline ^a   Liu, Xinggang ^a   Kiptanui, Zippora ^a   Khokhar, Bilal ^a   Al Jawadi, Mohammad H ^a   Zhu, Yue ^b   Zuckerman, Ilene H ^a,c  

^a UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c IMPAQ International LLC   (United States)

Author keywords

Anticoagulants; intracranial hemorrhage; traumatic brain injury; venous thromboembolism

Indexed keywords

ANTICOAGULANT AGENT; DALTEPARIN; ENOXAPARIN; HEPARIN; WARFARIN;

ANTICOAGULANT THERAPY; BLEEDING; BRAIN HEMORRHAGE; COMPRESSION INSTRUMENT; COMPUTER ASSISTED TOMOGRAPHY; DEEP VEIN THROMBOSIS; HEAD INJURY; HUMAN; INJURY SCALE; INJURY SEVERITY; LUNG EMBOLISM; MORTALITY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK ASSESSMENT; SUBDURAL HEMATOMA; SYSTEMATIC REVIEW; THROMBOSIS PREVENTION; TRAUMATIC BRAIN INJURY; VEIN THROMBOSIS; VENOUS THROMBOEMBOLISM; BRAIN INJURIES; COMPLICATION;

ANTICOAGULANTS; BRAIN INJURIES; HUMANS; RISK ASSESSMENT;

EID: 84938485073     PISSN: 08859701     EISSN: 1550509X     Source Type: Journal    
DOI: 10.1097/HTR.0000000000000077     Document Type: Review

References (54)

1. Faul MXL, Wald MM, Coronado VG. Traumatic Brain Injury in the United States: Emergency Department Visits, Hospitalizations and Deaths 2002-2006. Atlanta, GA: Centers for Disease Control and Prevention; 2010.
2. Rogers FB, Cipolle MD, Velmahos G, Rozycki G, Luchette FA. Practice management guidelines for the prevention of venous thromboembolism in trauma patients: the EAST Practice Management Guidelines Work Group. J Trauma. 2002;53(1):142-164.
3. Dennis JW, Menawat S, Von Thron J, et al. Efficacy of deep venous thrombosis prophylaxis in trauma patients and identification of high-risk groups. J Trauma Inj Infect Crit Care. 1993;35(1):132-138.
4. Greenfield LJ, Proctor MC, Rodriguez JL, Luchette FA, Cipolle MD, Cho J. Posttrauma thromboembolism prophylaxis. J Trauma. 1997;42(1):100-103.
5. Knudson MM, Ikossi DG, Khaw L, Morabito D, Speetzen LS. Thromboembolism after trauma: an analysis of 1602 episodes from the American College of Surgeons National Trauma Data Bank. Ann Surg. 2004;240(3):490-496; discussion 496-498.
6. Denson K, Morgan D, Cunningham R, et al. Incidence of venous thromboembolism in patients with traumatic brain injury. Am J Surg. 2007;193(3):380-383; discussion 383-384.
7. Geerts WH, Code KI, Jay RM, Chen E, Szalai JP. A prospective study of venous thromboembolism after major trauma. New Engl J Med. 1994;331(24):1601-1606.
8. Levy AS, Salottolo K, Bar-Or R, et al. Pharmacologic thromboprophylaxis is a risk factor for hemorrhage progression in a subset of patients with traumatic brain injury. J Trauma. 2010;68(4):886-894.
9. Bratton SL, Chestnut RM, Ghajar J, et al. Guidelines for the management of severe traumatic brain injury, part v: deep vein thrombosis prophylaxis. J Neurotrauma. 2007;24(suppl 1):S32-S36.
10. Dudley RR, Aziz I, Bonnici A, et al. Early venous thromboembolic event prophylaxis in traumatic brain injury with low-molecular-weight heparin: risks and benefits. J Neurotrauma. 2010;27(12):2165-2172.
11. Koehler DM, Shipman J, Davidson MA, Guillamondegui O. Is early venous thromboembolism prophylaxis safe in trauma patients with intracranial hemorrhage. J Trauma. 2011;70(2):324-329.
12. Scudday T, Brasel K, Webb T, et al. Safety and efficacy of prophylactic anticoagulation in patients with traumatic brain injury. J AmColl Surg. 2011;213(1):148-153; discussion 153-144.
13. Norwood SH, Berne JD, Rowe SA, Villarreal DH, Ledlie JT. Early venous thromboembolism prophylaxis with enoxaparin in patients with blunt traumatic brain injury. J Trauma. 2008;65(5):1021-1026; discussion 1026-1027.
14. Norwood SH, McAuley CE, Berne JD, et al. Prospective evaluation of the safety of enoxaparin prophylaxis for venous thromboembolism in patients with intracranial hemorrhagic injuries. Arch Surg. 2002;137(6):696-701; discussion 701-692.
15. Phelan HA. Pharmacologic venous thromboembolism prophylaxis after traumatic brain injury: a critical literature review. J Neurotrauma. 2012;29(10):1821-1828.
16. Nishijima DK, Offerman SR, Ballard DW, et al. Immediate and delayed traumatic intracranial hemorrhage in patients with head trauma and preinjury warfarin or clopidogrel use. Ann Emerg Med. 2012;59(56):460-468.
17. Sarani B, Temple-Lykens B, Kim P, et al. Factors associated with mortality and brain injury after falls from the standing position. J Trauma. 2009;67(5):954-958.
18. David M, Alessandro L, Jennifer T, Douglas GA. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg. 2009;8:336-341.
19. Schweizer M, Perencevich E, McDanel J, et al. Effectiveness of a bundled intervention of decolonization and prophylaxis to decrease Gram positive surgical site infections after cardiac or orthopedic surgery: systematic review and meta-analysis. BMJ. 2013;346:f2743.
20. Sharma S, Takyar S, Manson SC, Powell S, Penel N. Efficacy and safety of pharmacological interventions in second-or laterline treatment of patients with advanced soft tissue sarcoma: a systematic review. BMC Cancer. 2013;13:385.
21. ZhuW, Wu Y, Xu D, et al. Aspirin use and risk of age-related macular degeneration: a meta-analysis. PLoS One. 2013;8(3):e58821.
22. Downs SH, Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and nonrandomised studies of health care interventions. J Epidemiol Community Health. 1998;52(6):377-384.
23. Brathwaite CE, Mure AJ, O'Malley KF, Spence RK, Ross SE. Complications of anticoagulation for pulmonary embolism in low-risk trauma patients. Chest. 1993;104(3):718-720.
24. Cothren CC, Biffl WL, Moore EE, Kashuk JL, Johnson JL. Treatment for blunt cerebrovascular injuries: equivalence of anticoagulation and antiplatelet agents. Arch Surg. 2009;144(7): 685-690.
25. Fabian TC, Patton JH Jr, Croce MA, Minard G, Kudsk KA, Pritchard FE. Blunt carotid injury. Importance of early diagnosis and anticoagulant therapy. Ann Surg. 1996;223(5):513-522.
26. Gando S, Tedo I, KubotaM. Posttrauma coagulation and fibrinolysis. Crit Care Med. 1992;20(5):594-600.
27. Kurtoglu M, Yanar H, Bilsel Y, et al. Venous thromboembolism prophylaxis after head and spinal trauma: intermittent pneumatic compression devices versus low-molecular-weight heparin. World J Surg. 2004;28(8):807-811.
28. Maxwell RA, Chavarria-Aguilar M, CockerhamWT, et al. Routine prophylactic vena cava filtration is not indicated after acute spinal cord injury. J Trauma. 2002;52(5):902-906.
29. Meyer CS, Blebea J, Davis K Jr, Fowl RJ, Kempczinski RF. Surveillance venous scans for deep venous thrombosis in multiple trauma patients. Ann Vasc Surg. 1995;9(1):109-114.
30. Miller PR, Fabian TC, Bee TK, et al. Blunt cerebrovascular injuries: diagnosis and treatment. J Trauma. 2001;51(2):279-286.
31. Miller PR, Fabian TC, Croce MA, et al. Prospective screening for blunt cerebrovascular injuries: analysis of diagnostic modalities and outcomes. Ann Surg. 2002;236(3):386-393; discussion 393-385.
32. Nathens AB, McMurrayMK, Cuschieri J, et al. The practice of venous thromboembolism prophylaxis in the major trauma patient. J Trauma. 2007;62(3):557-563.
33. Owings JT, Bagley M, Gosselin R, Romac D, Disbrow E. Effect of critical injury on plasma antithrombin activity: low antithrombin levels are associated with thromboembolic complications. J Trauma Inj Infect Crit Care. 1996;41(3):396-405.
34. Praeger AJ, Westbrook AJ, Nichol AD, et al. Deep vein thrombosis and pulmonary embolus in patients with traumatic brain injury: a prospective observational study. Crit Care Resusc. 2012;14(1): 10-13.
35. Radecki RT, Gaebler-Spira D. Deep vein thrombosis in the disabled pediatric population. Arch PhysMedRehabil. 1994;75(3):248-250.
36. Spain DA, Bergamini TM, Hoffmann JF, Carrillo EH, Richardson JD. Comparison of sequential compression devices and foot pumps for prophylaxis of deep venous thrombosis in high-risk trauma patients. Am Surg. 1998;64(6):522-525.
37. Velmahos GC, Nigro J, Tatevossian R, et al. Inability of an aggressive policy of thromboprophylaxis to prevent deep venous thrombosis (DVT) in critically injured patients: are current methods of DVT prophylaxis insufficient? J Am Coll Surg. 1998;187(5):529-533.
38. Ungerstedt JS, Grenander A, Bredbacka S, Blomback M. Clotting onset time may be a predictor of outcome in human brain injury: a pilot study. J Neurosurg Anesthesiol. 2003;15(1):13-18.
39. Grenander A, Bredbacka S, Rydvall A, et al. Antithrombin treatment in patients with traumatic brain injury: a pilot study. J Neurosurg Anesthesiol. 2001;13(1):49-56.
40. Kim KS, Brophy GM. Symptomatic venous thromboembolism: incidence and risk factors in patients with spontaneous or traumatic intracranial hemorrhage. Neurocrit Care. 2009;11(1):28-33.
41. Kleindienst A, Harvey HB, Mater E, et al. Early antithrombotic prophylaxis with low-molecular-weight heparin in neurosurgery. Acta Neurochir. 2003;145(12):1085-1090; discussion 1090-1081.
42. O'Brien SH, Klima J, Gaines BA, Betz S, Zenati MS. Utilization of low-molecular-weight heparin prophylaxis in pediatric and adolescent trauma patients. J Trauma Nurs. 2012;19(2):117-121.
43. Pahatouridis D, Alexiou GA, Zigouris A, Mihos E, Drosos D, Voulgaris S. Coagulopathy in moderate head injury. The role of early administration of low-molecular-weight heparin. Brain Inj. 2010;24(10):1189-1192.
44. Senft C, Schuster T, Forster MT, Seifert V, Gerlach R. Management and outcome of patients with acute traumatic subdural hematomas and preinjury oral anticoagulation therapy. Neurol Res. 2009;31(10):1012-1018.
45. Carlile M, NicewanderD, Yablon SA, et al. Prophylaxis for venous thromboembolism during rehabilitation for traumatic brain injury: a multicenter observational study. J Trauma. 2010;68(4):916-923.
46. Phelan HA, Wolf SE, Norwood SH, et al. A randomized, doubleblinded, placebo-controlled pilot trial of anticoagulation in lowrisk traumatic brain injury: the delayed versus early enoxaparin prophylaxis I (DEEP I) study. J Trauma Acute Care Surg. 2012;73(6):1434-1441.
47. Eachempati SR, Vaslef SN, Sebastian MW, Reed RL II. Blunt vascular injuries of the head and neck: is heparinization necessary? J Trauma. 1998;45(6):997-1004.
48. Nickele CM, Kamps TK, Medow JE. Safety of a DVT chemoprophylaxis protocol following traumatic brain injury: a single center quality improvement initiative. Neurocrit Care. 2013;18(2):184-192.
49. Arnold JD, Dart BW, Barker DE, et al. Gold Medal Forum Winner. Unfractionated heparin three times a day versus enoxaparin in the prevention of deep vein thrombosis in trauma patients. Am Surg. 2010;76(6):563-570.
50. Minshall CT, Eriksson EA, Leon SM, Doben AR, McKinzie BP, Fakhry SM. Safety and efficacy of heparin or enoxaparin prophylaxis in blunt trauma patients with a head abbreviated injury severity score >2. J Trauma. 2011;71(2):396-399; discussion 399-400.
51. Kim J, Gearhart MM, Zurick A, Zuccarello M, James L, Luchette FA. Preliminary report on the safety of heparin for deep venous thrombosis prophylaxis after severe head injury. J Trauma. 2002;53(1):38-42; discussion 43.
52. Reiff DA, Haricharan RN, Bullington NM, Griffin RL, McGwin G Jr, Rue LW III. Traumatic brain injury is associated with the development of deep vein thrombosis independent of pharmacological prophylaxis. J Trauma. 2009;66(5):1436-1440.
53. Salottolo K, Offner P, Levy AS, Mains CW, Slone DS, Bar-Or D. Interrupted pharmocologic thromboprophylaxis increases venous thromboembolism in traumatic brain injury. J Trauma. 2011;70(1):19-24; discussion 25-16.
54. Depew AJ, Hu CK, Nguyen AC, Driessen N. Thromboembolic prophylaxis in blunt traumatic intracranial hemorrhage: a retrospective review. Am Surg. 2008;74(10):906-911.